Teveten 600mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Eprosartan mesilate

Available from:

Viatris UK Healthcare Ltd

ATC code:

C09CA02

INN (International Name):

Eprosartan mesilate

Dosage:

600mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 02050502; GTIN: 5012781062158

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER
TEVETEN
®
600MG TABLETS
(eprosartan mesilate)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor
or pharmacist.

This medicine has been prescribed for you. Do
not pass it on to others. It may harm them, even if
their symptoms are the same as yours.

If any of the side effects gets serious, or if you
notice any side effects not listed in this leaflet,
please tell your doctor or pharmacist.
The name of your medicine is Teveten 600mg
tablets but will be referred to as Teveten
throughout this leaflet. Please note that this leaflet
also contains information about other strength
Teveten 300mg tablets.
IN THIS LEAFLET:
1. WHAT TEVETEN IS AND WHAT IT IS USED FOR
2. BEFORE YOU TAKE TEVETEN
3. HOW TO TAKE TEVETEN
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE TEVETEN
6. FURTHER INFORMATION
1. WHAT TEVETEN IS AND WHAT IT IS USED FOR
WHAT TEVETEN IS USED FOR
Teveten contains a medicine called eprosartan
mesilate. This belongs to a group of medicines
called ‘angiotensin II receptor antagonists’.
This medicine is used to treat high blood pressure,
also called hypertension.
The main cause of high blood pressure is
narrowing of the blood vessels. This increases the
amount of work your heart must do to pump blood
around your body. You may not feel unwell, but, if
high blood pressure is not treated, it can lead to
heart disease and stroke.
HOW TEVETEN WORKS

Angiotensin II is a chemical found in the body
which makes your blood vessels contract. This
makes it more difficult for blood to pass through
them

This causes your blood pressure to rise

Teveten works by preventing the chemical,
angiotensin II, from causing your blood vessels to
contract. This has the effect of lowering your
blood pressure.
You may be given Teveten on its own or with
another medicine used to treat high blood
pressure. Using both medicines together will lower
your blood pres

Summary of Product characteristics

OBJECT 1
TEVETEN 600MG FILM-COATED TABLETS
Summary of Product Characteristics Updated 11-Apr-2018 | Mylan
Products Limited
1. Name of the medicinal product
Teveten 600mg film-coated tablets
2. Qualitative and quantitative composition
Eprosartan mesilate equivalent to 600mg eprosartan free base.
For excipients, see section 6.1.
3. Pharmaceutical form
Film-coated tablets.
Capsule-shaped, biconvex, white film-coated tablet with the
inscription '5046'.
4. Clinical particulars
4.1 Therapeutic indications
Eprosartan is indicated for the treatment of essential hypertension.
4.2 Posology and method of administration
The recommended dose is 600 mg eprosartan once daily.
Achievement of maximal blood pressure reduction in most patients may
take 2 to 3 weeks of treatment.
Eprosartan may be used alone or in combination with other
anti-hypertensives (see sections 4.3,4.4,4.5
and 5.1). In particular, addition of a thiazide-type diuretic such as
hydrochlorothiazide or a calcium
channel blocker such as sustained release nifedipine has been shown to
have an additive effect with
eprosartan.
Eprosartan may be taken with or without food.
GERIATRIC PATIENTS
No dose adjustment is required in the elderly.
DOSAGE IN HEPATICALLY IMPAIRED PATIENTS:
There is limited experience in patients with hepatic insufficiency
(see section 4.3).
DOSAGE IN RENALLY IMPAIRED PATIENTS:
In patients with moderate or severe renal impairment (creatinine
clearance <60 ml/min), the daily dose
should not exceed 600 mg.
PAEDIATRIC PATIENTS
Teveten is not recommended for use in children and adolescents due to
lack of data on safety and efficacy
4.3 Contraindications
Hypersensitivity to the active substance or to any of the excipients.
Second and third trimester of pregnancy (see sections 4.4 and 4.6).
Severe hepatic impairment.
Haemodynamically significant bilateral renovascular disease or severe
stenosis of a solitary functioning
kidney
The concomitant use of Teveten with aliskiren-containing products is
contraindicated in patients with
diabetes mellitus or renal